Parties In Zantac MDL Propose Path To 2023 Bellwether Trials

By Nathan Hale (October 25, 2021, 10:02 PM EDT) -- The parties in sprawling multidistrict litigation over alleged links between the heartburn drug Zantac and various cancers presented a joint plan Monday for narrowing a field of more than 130,000 potential personal injury claimants to serve as plaintiffs in initial bellwether trials targeted for 2023.

At the conclusion of a Zoom conference before West Palm Beach, Florida-based U.S. District Judge Robin L. Rosenberg, attorneys for the consumers and various drugmakers said they will meet in the next few days to address some remaining "gray" areas, but told the court they expect to still be able to commence the process with negligible...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!